AXT, Inc. 2015 Q3 Form 10-Q Summary
Business context and reporting period
AXT develops and manufactures compound and single-element semiconductor substrates, primarily gallium arsenide (GaAs), indium phosphide (InP), and germanium wafers, along with related raw materials. All manufacturing is conducted in China through subsidiaries and joint ventures. The unaudited filing covers the three and nine months ended September 30, 2015, compared with the corresponding 2014 periods.
Key financial metrics
| Metric | Q3 2015 | Q3 2014 | 9M 2015 | 9M 2014 |
|---|---|---|---|---|
| Revenue | $18.4 million | $23.1 million | $59.4 million | $63.9 million |
| Gross profit | $4.6 million | $5.3 million | $13.7 million | $12.2 million |
| Gross margin | 25.1% | 23.0% | 23.1% | 19.1% |
| Operating income (loss) | $(0.7) million | $0.7 million | $(3.2) million | $(2.3) million |
| Net income (loss) | $47,000 | $870,000 | $(728,000) | $(404,000) |
| Net income (loss) attributable to AXT | $42,000 | $644,000 | $(985,000) | $(1.1) million |
| Net income (loss) per diluted share | $(0.00) | $0.02 | $(0.03) | $(0.04) |
Q3 operating margin was approximately (3.9%) versus 2.8% in the prior-year quarter; nine-month operating margin was approximately (5.4%) versus (3.5%).
- Revenue declined 20.6% in Q3 and 7.0% year to date, primarily from lower GaAs substrate and raw-material sales. InP demand increased, supported by fiber-optic and data-connectivity applications.
- Gross margin improved due to product mix; year-to-date margin also benefited from lower material costs and cost-reduction efforts.
- SG&A increased 4.4% in Q3 and 19.3% year to date. Year-to-date expense included approximately $1.2 million of additional professional services related to the related-party investigation and higher stock-based compensation.
- R&D increased 42.8% in Q3 and 46.7% year to date because of higher product development, testing, and personnel costs.
- Other income was $496,000 in Q3 and $1.8 million year to date, including foreign-exchange gains, investment-sale gains, and more than $300,000 of Chinese government manufacturing subsidies during the year-to-date period.
Cash flow, liquidity, debt, and balance sheet
- Cash provided by operating activities was $2.3 million for the first nine months of 2015, broadly comparable with $2.3 million in the prior-year period.
- Investing activities used $2.1 million, including $3.5 million of capital expenditures and net purchases of investments.
- Financing activities used $2.2 million, primarily for $2.3 million of common-stock repurchases.
- Cash and cash equivalents declined to $26.2 million at September 30, 2015 from $28.8 million at December 31, 2014. Total cash, cash equivalents, and investments were approximately $45.4 million.
- Total assets were $153.1 million and total liabilities were $13.1 million at September 30, 2015. The filing reports no outstanding borrowings; the previously unused $10.0 million credit facility was terminated in January 2015.
- Approximately $18.6 million of cash and investments were held in foreign bank accounts, including $12.2 million that management indicated would not be available for U.S. use without potential U.S. income-tax consequences.
- Contractual obligations totaled $2.5 million, consisting primarily of operating leases and royalty commitments. No material off-balance-sheet financing arrangements were reported.
Material changes versus the prior comparable period
- Revenue weakened substantially, particularly in GaAs, raw materials, Europe, China, Japan, and other Asia-Pacific markets. Taiwan was the principal geographic region with growth.
- Despite lower revenue, gross margin improved by 210 basis points in Q3 and 400 basis points year to date.
- Operating results deteriorated in Q3 and remained loss-making year to date as lower revenue and higher operating expenses more than offset gross-margin improvement.
- Equity earnings from unconsolidated joint ventures fell 57.2% in Q3 and 48.3% year to date, reflecting lower raw-material selling prices and volumes.
- The company repurchased approximately 891,000 shares for $2.3 million during the first nine months, with approximately $2.7 million remaining under the program.
- Accumulated other comprehensive income declined primarily because of foreign-currency translation losses; total comprehensive loss attributable to AXT was $2.4 million in Q3 and $3.5 million year to date.
- There were no restructuring charges in 2015, compared with a $907,000 charge in the first quarter of 2014.
Guidance, outlook, commentary, and risks
- Management stated that existing cash and investments should be adequate to meet needs over the next twelve months, but warned that lower sales could reduce operating cash flow, accelerate cash usage, and require additional capital on uncertain terms.
- The filing does not provide a clear numerical revenue or earnings forecast for the next quarter or full year.
- A material regulatory contingency concerns a Chinese requirement for a permit to manufacture GaAs wafers after gallium arsenide was added to the hazardous-substances list. The company’s application was under review, and failure to obtain approval could require a production halt, employee furloughs, supply-chain disruption, and customer losses.
- The company disclosed an Audit Committee investigation into previously undisclosed historical related-party transactions involving former China operations executive Davis Zhang. The investigation found no intentional misconduct, improper benefit, or financial-statement inaccuracies, but resulted in approximately $1.8 million of professional-service fees.
- Key operating risks include GaAs substitution by silicon-based technologies, semiconductor cyclicality, customer concentration, declining average selling prices, underutilized manufacturing capacity, product-quality and yield issues, dependence on Chinese manufacturing and suppliers, foreign-currency volatility, and environmental or safety regulation.
- Two customers represented more than 10% of Q3 revenue, and the top five customers represented 45% of Q3 revenue. One customer represented more than 10% of accounts receivable at quarter end.
- Inventory totaled $38.1 million, including an $11.5 million reserve for excess and obsolete inventory. The company also maintained $12.5 million of strategic investments in privately held Chinese companies accounted for under the equity method.
- Management concluded that disclosure controls and procedures were effective as of September 30, 2015 and reported no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Current status and expected timing of the Chinese permit required for GaAs manufacturing.
- Whether weak GaAs and raw-material demand is stabilizing and whether InP growth can offset declines elsewhere.
- Customer concentration, order cancellations or delays, product qualification status, and accounts-receivable collectability.
- Sustainability of the improved gross margin amid pricing pressure, capacity utilization issues, and inventory risk.
- Cash availability in the United States, potential tax costs of repatriating foreign funds, and the company’s ability to fund capital expenditures and losses without new financing.
- Future foreign-exchange exposure, particularly to the Japanese yen and Chinese renminbi.
- Resolution and any continuing costs or disclosure implications from the related-party investigation.